ABVC BioPharma, Inc. (ABVC) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering ABVC BioPharma, Inc. (ABVC), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For ABVC BioPharma, Inc., analysts forecast revenue rising from $588,879 in 2021 to $35.28M in 2026; the average estimate for 2026 earnings per share is $1.30; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
ABVC BioPharma, Inc. (ABVC) forecast — frequently asked questions
What are analysts forecasting for ABVC BioPharma, Inc.'s earnings?
The average analyst estimate for ABVC BioPharma, Inc. (ABVC) earnings per share in 2026 is 1.30, with individual estimates between 1.30 and 1.30.
How much revenue is ABVC BioPharma, Inc. expected to make?
Analysts forecast ABVC BioPharma, Inc. (ABVC) revenue of $35.28M in 2026, based on 1 published estimates.
How many analysts cover ABVC?
1 analyst contribute estimates for ABVC BioPharma, Inc. (ABVC). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.